Dr Evan Matthew Jones, MD in Us Air Force, CO - Medicare

Dr Evan Matthew Jones, MD is a medicare enrolled "Orthopaedic Surgery - Hand Surgery" physician in Us Air Force, Colorado. His current practice location is 4102 Pinion Dr, Us Air Force, Colorado. You can reach out to his office (for appointments etc.) via phone at (719) 333-5081.

Dr Evan Matthew Jones is licensed to practice in Colorado (license number DR.0064800) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1023200524.

Contact Information

	Dr Evan Matthew Jones, MD
	4102 Pinion Dr, Us Air Force, CO 80840-2502
	(719) 333-5081
	Not Available

Physician's Profile

Full Name	Dr Evan Matthew Jones
Gender	Male
Speciality
Experience	Years
Location	4102 Pinion Dr, Us Air Force, Colorado
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Evan Matthew Jones attended and graduated from in

NPI Data:

NPI Number: 1023200524
Provider Enumeration Date: 08/17/2007
Last Update Date: 07/19/2022

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Dr Evan Matthew Jones such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1023200524	NPI	-	NPPES
9000205218	Medicaid	CO

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207XS0106X	Orthopaedic Surgery - Hand Surgery	01065888A (Indiana)	Secondary
207XS0106X	Orthopaedic Surgery - Hand Surgery	7868 (Alaska)	Secondary
207XS0106X	Orthopaedic Surgery - Hand Surgery	P1773 (Texas)	Secondary
207XS0106X	Orthopaedic Surgery - Hand Surgery	DR.0064800 (Colorado)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Evan Matthew Jones is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Evan Matthew Jones, MD 4102 Pinion Dr, Us Air Force, CO 80840-2502 Ph: (719) 333-5081	Dr Evan Matthew Jones, MD 4102 Pinion Dr, Us Air Force, CO 80840-2502 Ph: (719) 333-5081

News Archive

Modeling of COVID-19 seroprevalence and resurgence in Canada

Despite increased vaccine distribution and a significant decrease in the number of COVID-19 cases in Canada, the future of the pandemic is still a major concern, based on the possibility of a resurgence in the short term as well as long term and an understanding of the future of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity. It is not clear if the Canadian population will reach herd immunity or if there is a risk of future resurgence of the virus in the Fall or Winter.

Medical Nutrition launches Diff-Stat pre- and probiotic supplement to prevent the onset of AAD and C-diff

Medical Nutrition USA, Inc., a developer and distributor of uniquely engineered, nutrition-medicine products, announced the introduction of Diff-Stat™, a new supplement containing pre- and probiotics to help restore and maintain beneficial bacteria that prevent the onset of antibiotic-associated diarrhea (AAD) and clostridium difficile (C-diff).

Mini artificial liver grown from stem cells

Scientists in Britain have grown the first artificial liver from stem cells, which is the first step in a process which within 10 years could see livers being grown in a laboratory for human transplants.

Quest Diagnostics subsidiary initiates tender offer for Celera acquisition

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the outstanding shares of common stock (the "Shares") of Celera Corporation (Nasdaq: CRA), one of the world's pioneers in genetic diagnostics discovery and development for $8.00 per share in cash, without interest and less any required withholding taxes.

First use of technology called ubiquitin-mediated fluorescence complementation to study a cell-signaling mechanism called ubiquitination

Researchers at the University of Michigan Medical School and Howard Hughes Medical Institute have found a way to see proteins in cells that have been tagged by a molecular "sticky note" called ubiquitin.

Dr Evan Matthew Jones, MD - Medicare in Us Air Force, CO